The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Very Late Stent Thrombosis and Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation: Five-Year Outcome of the j-Cypher Registry
Abstract
Background—: There is a scarcity of long-term data from large-scale drug-eluting stent registries with a large enough sample to evaluate low-frequency events such as stent thrombosis (ST). Methods and Results—: Five-year outcomes were evaluated in 12 812 consecutive patients undergoing sirolimus-eluting stent (SES) implantation in the j-Cypher registry. Cumulative incidence of definite ST was low (30 day, 0.3%; 1 year, 0.6%; and 5 years, 1.6%). However, late and very late ST continued to occur without attenuation up to 5 years after sirolimus-eluting stent implantation (0.26%/y). Cumulative incidence of target lesion revascularization within the first year was low (7.3%). However, late target lesion revascularization beyond 1 year also continued to occur without attenuation up to 5 years (2.2%/y). Independent risk factors of ST were completely different according to the timing of ST onset, suggesting the presence of different pathophysiological mechanisms of ST according to the timing of ST onset: acute coronary syndrome and target of proximal left anterior descending coronary artery for early ST; side-branch stenting, diabetes mellitus, and end-stage renal disease with or without hemodialysis for late ST; and current smoking and total stent length >28 mm for very late ST. Independent risk factors of late target lesion revascularization beyond 1 year were generally similar to those risk factors identified for early target lesion revascularization. Conclusion—: Late adverse events such as very late ST and late target lesion revascularization are continuous hazards, lasting at least up to 5 years after implantation of the first-generation drug-eluting stents (sirolimus-eluting stents), which should be the targets for developing improved coronary stents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents
Mauri, L., Hsieh, W.-H., Massaro, J. M., Ho, K. K. L., D'Agostino, R., & Cutlip, D. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067731 · Cited by 1,441
Serruys, P. W., Ong, A. T. L., van Herwerden, L. A., Sousa, J. E., Jatene, A., Bonnier, J. J. R. M., Schönberger, J. P. M. A., Buller, N., Bonser, R., Disco, C., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.082 · Cited by 608
Kirtane, A. J., Gupta, A., Iyengar, S., Moses, J. W., Leon, M. B., Applegate, R., Brodie, B., Hannan, E., Harjai, K., Jensen, L. O., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.826479 · Cited by 577
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
Park, S.-J., Park, D.-W., Kim, Y.-H., Kang, S.-J., Lee, S.-W., Lee, C. W., Han, K.-H., Park, S.-W., Yun, S.-C., Lee, S.-G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001266 · Cited by 511
Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice
Wenaweser, P., Daemen, J., Zwahlen, M., van Domburg, R., Jüni, P., Vaina, S., Hellige, G., Tsuchida, K., Morger, C., Boersma, E., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.006 · Cited by 481
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
Kimura, T., Morimoto, T., Nakagawa, Y., Tamura, T., Kadota, K., Yasumoto, H., Nishikawa, H., Hiasa, Y., Muramatsu, T., Meguro, T., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808311 · Cited by 358
Self-citationKimura, T., Morimoto, T., Kozuma, K., Honda, Y., Kume, T., Aizawa, T., Mitsudo, K., Miyazaki, S., Yamaguchi, T., Hiyoshi, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.903955 · Cited by 238
Self-citationUse of Drug-Eluting Stents in Acute Myocardial Infarction
Brar, S. S., Leon, M. B., Stone, G. W., Mehran, R., Moses, J. W., Brar, S. K., & Dangas, G. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.013 · Cited by 148
5-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation
Caixeta, A. M., Leon, M. B., Lansky, A. J., Nikolsky, E., Aoki, J., Moses, J. W., Schofer, J. J., Morice, M., Schampaert, É., Kirtane, A. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.077 · Cited by 146
Long-Term Safety and Efficacy With Paclitaxel-Eluting Stents
Ellis, S. G., Stone, G. W., Cox, D. A., Hermiller, J. B., O’Shaughnessy, C. D., Mann, T., Turco, M. A., Caputo, R. P., Bergin, P. J., Bowman, T. S., et al. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.10.003 · Cited by 129
Ikari, Y., Kotani, J., Kozuma, K., Kyo, E., Nakamura, M., Yokoi, H., & The J-PMS study group (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0732 · Cited by 49
Cited by
Otsuka, F., Byrne, R. A., Yahagi, K., Mori, H., Ladich, E., Fowler, D. R., Kutys, R., Xhepa, E., Kastrati, A., Virmani, R., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv205 · Cited by 491
Kandzari, D. E., Mauri, L., Koolen, J. J., Massaro, J. M., Doros, G., Garcia-Garcia, H. M., Bennett, J., Roguin, A., Gharib, E. G., Cutlip, D. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32249-3 · Cited by 279
Kimura, T., Kozuma, K., Tanabe, K., Nakamura, S., Yamane, M., Muramatsu, T., Saito, S., Yajima, J., Hagiwara, N., Mitsudo, K., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv435 · Cited by 274
Self-citationCoronary Artery Disease and Diabetes Mellitus
Aronson, D., & Edelman, E. R. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.001 · Cited by 222
Ito, T., Fujita, H., Tani, T., & Ohte, N. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.026 · Cited by 30
Metadata
- Authors
- Kimura, T., Morimoto, T., Nakagawa, Y., Kawai, K., Miyazaki, S., Muramatsu, T., Shiode, N., Namura, M., Sone, T., Oshima, S., Nishikawa, H., Hiasa, Y., Hayashi, Y., Nobuyoshi, M., Mitudo, K., & on Behalf of the j-Cypher Registry Investigators
- Venue
- Circulation
- Published
- 2012-01-31
- Volume
- 125
- Issue
- 4
- Pages
- 584-591
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2027717053
- Cited by
- 268
- References
- 12
- FWCI
- 33.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.